Greenlane - GNLN Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Greenlane in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" GNLN shares.
View GNLN analyst ratings or view top-rated stocks.

3 Wall Street research analysts have issued 1 year price targets for Greenlane's stock. Their GNLN share price forecasts range from $2.00 to $40.00. On average, they anticipate the company's share price to reach $21.75 in the next year. This suggests a possible upside of 4,082.7% from the stock's current price.
View analysts price targets for GNLN or view top-rated stocks among Wall Street analysts.

Greenlane's stock was trading at $0.2875 at the beginning of the year. Since then, GNLN shares have increased by 80.9% and is now trading at $0.52.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023.
View our GNLN earnings forecast.

Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Tuesday, November, 15th. The company reported ($11.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.20) by $10.23. The business had revenue of $28.68 million for the quarter, compared to analyst estimates of $36.56 million. Greenlane had a negative net margin of 64.02% and a negative trailing twelve-month return on equity of 65.46%. During the same quarter in the previous year, the firm earned ($6.60) earnings per share.

Greenlane shares reverse split on the morning of Wednesday, August 10th 2022. The 1-20 reverse split was announced on Wednesday, August 10th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 10th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlane investors own include KushCo (KSHB), Organigram (OGI), Enerplus (ERF), Matinas BioPharma (MTNB), Supreme Cannabis (SPRWF), ADMA Biologics (ADMA), EnLink Midstream (ENLC), Gran Tierra Energy (GTE), MariMed (MRMD) and Novan (NOVN).

(GNLN) raised $80 million in an initial public offering (IPO) on Thursday, April 18th 2019. The company issued 5,300,000 shares at $14.00-$16.00 per share. Cowen and Company and Canaccord Genuity acted as the underwriters for the IPO and Ladenburg Thalmann, Roth Capital Partners and Northland Securities were co-managers.

Greenlane trades on the NASDAQ under the ticker symbol "GNLN."

Greenlane's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Aaron Locascio, Adam Schoenfeld and William E Mote Jr.
View institutional ownership trends.

Shares of GNLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GNLN stock can currently be purchased for approximately $0.52.

Greenlane (NASDAQ:GNLN) has a market capitalization of $3.97 million and generates $166.06 million in revenue each year. The company earns $-30,580,000.00 in net income (profit) each year or ($18.90) on an earnings per share basis.

The company employs 264 workers across the globe.

Greenlane's mailing address is 1095 BROKEN SOUND PARKWAY SUITE 300, BOCA RATON FL, 33487. The official website for the company is www.gnln.com. The company can be reached via phone at (877) 292-7660 or via email at investor@gnln.com.